Literature DB >> 34333715

Pharmacogenomics in cancer supportive care: key issues and future directions.

Jai N Patel1, Ian Olver2, Fred Ashbury3,4,5.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34333715     DOI： 10.1007/s00520-021-06451-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  22 in total

1.  Precision medicine-based drug treatment individualization in oncology.

Authors:  Jennifer H Martin; Ian Olver
Journal:  Br J Clin Pharmacol       Date:  2020-12-13       Impact factor: 4.335

2.  The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy.

Authors:  D Brixner; E Biltaji; A Bress; S Unni; X Ye; T Mamiya; K Ashcraft; J Biskupiak
Journal:  J Med Econ       Date:  2015-11-11       Impact factor: 2.448

3.  Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy.

Authors:  Daiki Tsuji; Megumi Matsumoto; Yohei Kawasaki; Yong-I L Kim; Keisuke Yamamoto; Hidenori Nakamichi; Yuri Sahara; Ryo Makuta; Mari Yokoi; Takehiro Miyagi; Kunihiko Itoh
Journal:  Cancer Chemother Pharmacol       Date:  2020-10-24       Impact factor: 3.333

Review 4.  Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.

Authors:  G C Bell; K E Caudle; M Whirl-Carrillo; R J Gordon; K Hikino; C A Prows; A Gaedigk; Jag Agundez; S Sadhasivam; T E Klein; M Schwab
Journal:  Clin Pharmacol Ther       Date:  2017-04-06       Impact factor: 6.875

Review 5.  Pharmacogenomics knowledge for personalized medicine.

Authors:  M Whirl-Carrillo; E M McDonagh; J M Hebert; L Gong; K Sangkuhl; C F Thorn; R B Altman; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2012-10       Impact factor: 6.875

6.  Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.

Authors:  Dyah A Perwitasari; Judith A M Wessels; Robert J H M van der Straaten; Renee F Baak-Pablo; Mustofa Mustofa; Mohammad Hakimi; Johann W R Nortier; Hans Gelderblom; Henk-Jan Guchelaar
Journal:  Jpn J Clin Oncol       Date:  2011-08-11       Impact factor: 3.019

7.  Codeine intoxication associated with ultrarapid CYP2D6 metabolism.

Authors:  Yvan Gasche; Youssef Daali; Marc Fathi; Alberto Chiappe; Silvia Cottini; Pierre Dayer; Jules Desmeules
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

8.  The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.

Authors:  Andrea Gaedigk; Magnus Ingelman-Sundberg; Neil A Miller; J Steven Leeder; Michelle Whirl-Carrillo; Teri E Klein
Journal:  Clin Pharmacol Ther       Date:  2017-11-14       Impact factor: 6.875

9.  All You Need to Know About DPYD Genetic Testing for Patients Treated With Fluorouracil and Capecitabine: A Practitioner-Friendly Guide.

Authors:  Federico Innocenti; Sarah C Mills; Hanna Sanoff; Joseph Ciccolini; Heinz-Josef Lenz; Gerard Milano
Journal:  JCO Oncol Pract       Date:  2020-11-16

10.  Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.

Authors:  Miles C Andrews; Connie P M Duong; Vancheswaran Gopalakrishnan; Valerio Iebba; Wei-Shen Chen; Lisa Derosa; Md Abdul Wadud Khan; Alexandria P Cogdill; Michael G White; Matthew C Wong; Gladys Ferrere; Aurélie Fluckiger; Maria P Roberti; Paule Opolon; Maryam Tidjani Alou; Satoru Yonekura; Whijae Roh; Christine N Spencer; Irina Fernandez Curbelo; Luis Vence; Alexandre Reuben; Sarah Johnson; Reetakshi Arora; Golnaz Morad; Matthew Lastrapes; Erez N Baruch; Latasha Little; Curtis Gumbs; Zachary A Cooper; Peter A Prieto; Khalida Wani; Alexander J Lazar; Michael T Tetzlaff; Courtney W Hudgens; Margaret K Callahan; Matthew Adamow; Michael A Postow; Charlotte E Ariyan; Pierre-Olivier Gaudreau; Luigi Nezi; Didier Raoult; Catalin Mihalcioiu; Arielle Elkrief; Rossanna C Pezo; Lauren E Haydu; Julie M Simon; Hussein A Tawbi; Jennifer McQuade; Patrick Hwu; Wen-Jen Hwu; Rodabe N Amaria; Elizabeth M Burton; Scott E Woodman; Stephanie Watowich; Adi Diab; Sapna P Patel; Isabella C Glitza; Michael K Wong; Li Zhao; Jianhua Zhang; Nadim J Ajami; Joseph Petrosino; Robert R Jenq; Michael A Davies; Jeffrey E Gershenwald; P Andrew Futreal; Padmanee Sharma; James P Allison; Bertrand Routy; Laurence Zitvogel; Jennifer A Wargo
Journal:  Nat Med       Date:  2021-07-08       Impact factor: 87.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.